Rajeev A. Modi - 01 Mar 2026 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role: Executive Vice President U.S. Pet Health and Global Digital Transformation
Signature: /s/ Amy C. Seidel, as Attorney-in-Fact for Rajeev A. Modi
Issuer symbol: ELAN
Transactions as of: 01 Mar 2026
Net transactions value: -$511,500
Form type: 4
Filing time: 03 Mar 2026, 19:19:07 UTC
Previous filing: 24 Feb 2026
Next filing: 05 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Modi Rajeev A.	Executive Vice President U.S. Pet Health and Global Digital Transformation	C/O ELANCO ANIMAL HEALTH INCORPORATED, 450 ELANCO CIRCLE, INDIANAPOLIS	/s/ Amy C. Seidel, as Attorney-in-Fact for Rajeev A. Modi	03 Mar 2026	0001916473

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELAN	Common Stock	Award	$0	+41,690	+34%	$0.000000	165,463	01 Mar 2026	Direct	F1
transaction	ELAN	Common Stock	Tax liability	$511,500	-19,375	-12%	$26.40	146,088	01 Mar 2026	Direct
transaction	ELAN	Common Stock	Award	$0	+14,205	+9.7%	$0.000000	160,293	01 Mar 2026	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELAN	Employee Stock Option (right to buy)	Award	$0	+29,025		$0.000000	29,025	01 Mar 2026	Common Stock	29,025	$26.40	Direct	F3
transaction	ELAN	Deferred Stock Units (Match)	Award	$0	+2,532		$0.000000	2,532	01 Mar 2026	Common Stock	2,532		Direct	F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 691 shares acquired on January 31, 2026 under Elanco Animal Health Inc.'s Employee Stock Purchase Plan
F2	Grant of restricted stock units vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029.
F3	Grant of stock options vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029.
F4	Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
F5	Deferred stock units vest December 31, 2027 and settle upon termination of employment or otherwise in accordance with the Executive Deferral and Stock Match Plan.

Remarks:

Executive Vice President U.S. Pet Health and Global Digital Transformation